07/2015
Shanghai RunYoung Investment Management Company was established.
12/2018
Hosted the 1st Sino-Israeli Medical Technology Industry Summit Forum in Beijing in cooperation with the Central Committee of the Chinese Peasants’ and Workers’ Democratic Party.
03/2019
Signed an Exclusive Framework Cooperation Agreement with The Hebrew University Yissum technology transfer center.
05/2019
Hosted the 2nd Sino-Israeli Medical Technology Industry Summit Forum in Changzhou in cooperation with the Central Committee of the Chinese Peasants’ and Workers’ Democratic Party.
06/2019
Changzhou RunYoung Technology Transfer Center Company was established.
11/2019
Signed an exclusive framework cooperation agreement with Mor Research Applications, the technology transfer office of the largest HMO in Israel; Clalit Health Services.
12/2019
Invested in BrainQ, an Israeli company that has developed neuro-recovery technology for various neurological diseases.
01/2020
Completed investment in Professor ELI Keshet’s (an academician of the Israeli Academy of Sciences) project to promote healthy aging through vascular regulation of VEGF.
01/2020
Jointly established the West Taihu Lake China-Israel Biomedical Innovation Research Institute with Changzhou No. 4 Pharmaceutical Co.
02/2020
Invested in the LIFT (Liquid Foam Therapy) drug delivery technology in Israel.
04/2020
Invested in Israel’s VESSL technology platform; a combination of cell and gene therapy.
05/2020
Invested in Israel’s AMD dry (atrophic) geriatric shift lesion project.
05/2020
Signed nobel laureate Aaron Ciechanover as Honorary Chairman of RunYoung.
07/2020
Built a medical device incubation platform in partnership with Hangzhou Kangji Medical Group.
09/2020
Signed an exclusive partnership agreement with Sheba Medical Cente; a top ten hospital globally.
10/2020
Signed a strategic cooperation agreement with CW Data to bring more Israeli technologies to China.
March 2021
Completed investment in Nobel Prize Winner Aaron Ciechanover‘s project to diagnose and treat multiple myeloma.